161 related articles for article (PubMed ID: 25174340)
1. Nanotheranostics in evidence based personalized medicine.
Sharma S
Curr Drug Targets; 2014; 15(10):915-30. PubMed ID: 25174340
[TBL] [Abstract][Full Text] [Related]
2. Nanotheranostics for personalized medicine.
Mura S; Couvreur P
Adv Drug Deliv Rev; 2012 Oct; 64(13):1394-416. PubMed ID: 22728642
[TBL] [Abstract][Full Text] [Related]
3. Targeted nanotheranostics for personalized cancer therapy.
Diou O; Tsapis N; Fattal E
Expert Opin Drug Deliv; 2012 Dec; 9(12):1475-87. PubMed ID: 23092183
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of metallothioneins in cell therapy and nanomedicine.
Sharma S; Rais A; Sandhu R; Nel W; Ebadi M
Int J Nanomedicine; 2013; 8():1477-88. PubMed ID: 23620664
[TBL] [Abstract][Full Text] [Related]
5. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
[TBL] [Abstract][Full Text] [Related]
6. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
7. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine and drug delivery.
Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
[TBL] [Abstract][Full Text] [Related]
9. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
Muthu MS; Leong DT; Mei L; Feng SS
Theranostics; 2014; 4(6):660-77. PubMed ID: 24723986
[TBL] [Abstract][Full Text] [Related]
10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
11. Smart blood cell and microvesicle-based Trojan horse drug delivery: Merging expertise in blood transfusion and biomedical engineering in the field of nanomedicine.
Wu YW; Goubran H; Seghatchian J; Burnouf T
Transfus Apher Sci; 2016 Apr; 54(2):309-18. PubMed ID: 27179926
[TBL] [Abstract][Full Text] [Related]
12. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
13. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
Tekchandani P; Kurmi BD; Paliwal SR
Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
[TBL] [Abstract][Full Text] [Related]
15. Nanotheranostics for personalized medicine.
Kim TH; Lee S; Chen X
Expert Rev Mol Diagn; 2013 Apr; 13(3):257-69. PubMed ID: 23570404
[TBL] [Abstract][Full Text] [Related]
16. Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision.
Sahakyan N; Haddad A; Richardson S; Forcha-Etieundem V; Christopher L; Alharbi H; Campbell R
Anticancer Agents Med Chem; 2017; 17(8):1033-1039. PubMed ID: 28042778
[TBL] [Abstract][Full Text] [Related]
17. Novel applications of nanotechnology in medicine.
Surendiran A; Sandhiya S; Pradhan SC; Adithan C
Indian J Med Res; 2009 Dec; 130(6):689-701. PubMed ID: 20090129
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.
Rizzo LY; Theek B; Storm G; Kiessling F; Lammers T
Curr Opin Biotechnol; 2013 Dec; 24(6):1159-66. PubMed ID: 23578464
[TBL] [Abstract][Full Text] [Related]
19. Cancer nanotheranostics: Strategies, promises and impediments.
Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
[TBL] [Abstract][Full Text] [Related]
20. Biologics, theranostics, and personalized medicine in drug delivery systems.
Puccetti M; Pariano M; Schoubben A; Giovagnoli S; Ricci M
Pharmacol Res; 2024 Mar; 201():107086. PubMed ID: 38295917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
